A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1992
12/06/1992	WO1992021369A1 Synthetic calcitonin peptides
12/06/1992	CA2088922A1 Synthetic calcitonin peptides
12/06/1992	CA2070468A1 Fatty acid treatment
12/05/1992	CA2070149A1 Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty
12/04/1992	WO1992021979A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/04/1992	CA2103142A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/02/1992	EP0516594A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
12/02/1992	EP0516350A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
12/02/1992	EP0516349A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
12/02/1992	EP0516082A2 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents
12/02/1992	EP0516015A1 Substituted decarestrictines, methods for their preparation and use thereof
12/02/1992	EP0515755A1 A diet for suppressing the absorption of saccharides
12/02/1992	EP0515460A1 Docosahexaenoic acid, methods for its production and compounds containing the same
12/02/1992	EP0515456A1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them.
12/02/1992	CN1066653A Benzoheterocyclic compounds
12/01/1992	WO1992021356A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	WO1992021352A1 USE OF 1-(β-D-ARABINOFURANOSYL)-5-PROPYNYLURACIL FOR LOWERING SERUM CHOLESTEROL
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	CA2103246A1 Hypertonic isochloremic formulation for circulatory shock
12/01/1992	CA2088264A1 Nucleoside derivative
12/01/1992	CA2069548A1 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents
12/01/1992	CA2068744A1 Gallium compounds
12/01/1992	CA1310967C Substituted thiacycloalkeno [3,2-b] pyridines, methods of preparation, compositions and method of use
12/01/1992	CA1310965C Indolizine derivatives, process for preparing them and the compositions containing them
11/1992
11/30/1992	WO1992021641A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2109515A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2069520A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
11/29/1992	CA2068378A1 Chemical compounds
11/29/1992	CA2068377A1 Chemical compounds
11/26/1992	WO1992020804A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
11/26/1992	WO1992020707A1 Bombesin analogs
11/26/1992	WO1992020706A1 Endothelin antagonists
11/26/1992	WO1992020679A1 Benzofuran derivatives
11/26/1992	WO1992020650A2 Phosphite-borane compounds, and method of making and using the same
11/26/1992	WO1992020371A1 Targeted delivery of bone growth factors
11/26/1992	WO1992020367A1 Treatment of anorexia and related states
11/26/1992	WO1992020366A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/26/1992	WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	WO1992020241A1 Nutrient preparation
11/26/1992	WO1992017446A3 Pyridazinone acetic acids aldose reductase inhibitors
11/26/1992	CA2109794A1 Amylin and possibly insulin containing composition for the treatment of anorexia and related states
11/26/1992	CA2109604A1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/26/1992	CA2108880A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	CA2108754A1 Endothelin antagonists
11/26/1992	CA2102195A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
11/25/1992	EP0515301A2 Improvements in benzodiazepine treatment by cholinesterterase inhibitors
11/25/1992	EP0515228A2 Essential pure human parathyroid hormone
11/25/1992	EP0514851A1 N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
11/25/1992	EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/25/1992	EP0514667A1 Benzazepin derivatives as vasopressin antagonists
11/24/1992	US5166142 Use of type ia antiarrhythmic agents to lower blood lipids
11/24/1992	CA1310638C Imidazo-benzodiazepines and their use in the treatment of memory or cerebral senescence disorders
11/19/1992	EP0514197A1 Anti-hypertensive benzofuran derivatives substituted by N-imidazolyl-methyl groups which are condensed with optionally nitrogen containing, six-membered rings
11/19/1992	EP0514133A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
11/19/1992	EP0514130A2 Bone acidic glycoprotein (BAG-75) for inhibiting bone resorption
11/19/1992	EP0514124A2 Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol
11/19/1992	EP0514056A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry
11/19/1992	EP0513761A2 Bisphosphonate squalene synthetase inhibitors
11/19/1992	EP0513760A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol
11/19/1992	EP0513387A1 Active oxygen inhibitor
11/19/1992	EP0513177A1 5-oxygenated-2,4,6-triaminopyrimidines
11/19/1992	DE4116004A1 Naehrstoffzubereitung Naehrstoffzubereitung
11/17/1992	US5164400 Pyrroloquinoline compounds
11/17/1992	US5164373 Blodd-coagulation factor XIII
11/17/1992	US5164368 Treatment for osteoporosis using growth hormone releasing factor (grf) in combination with parathyroid hormone (pth)
11/17/1992	US5164366 Diabetes
11/17/1992	US5164189 Single layer transdermal drug administration system
11/17/1992	CA2068756A1 Benzofuran derivatives
11/17/1992	CA1310320C Antihypercholesterolemic compounds
11/17/1992	CA1310317C Prodrugs of antihypercholesterolemic compounds
11/17/1992	CA1310269C Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
11/15/1992	CA2068355A1 Benzodiazephine derivatives, compositions containing them and their use in therapy
11/14/1992	CA2068550A1 Method for lowering cholesterol employing bisphosphonate squalene synthetase inhibitors
11/14/1992	CA2068389A1 Method for inhibiting bone resorption
11/14/1992	CA2067974A1 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
11/14/1992	CA2067967A1 Bisphosphonate squalene synthetase inhibitors and method
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019640A1 A substance for lowering high cholesterol level in serum and a method for preparing the same
11/12/1992	WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
11/12/1992	WO1992019617A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/12/1992	WO1992019614A1 4-aryl-3-(heteroarylureido)quinoline derivatives
11/12/1992	WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/12/1992	WO1992019253A1 CCK ANALOGS CONTAINING α-SUBSTITUTED AMINO ACIDS
11/12/1992	WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes
11/12/1992	CA2106765A1 Cck analogs containing ó-substituted amino acids
11/12/1992	CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes
11/11/1992	EP0512899A1 Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them
11/11/1992	EP0512844A1 Targeted delivery of bone growth factors
11/11/1992	EP0512754A1 Reduction products of rapamycin as immunosuppressants antiinflammatory or antifungal agents
11/11/1992	EP0512570A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/11/1992	EP0512400A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/11/1992	EP0512076A1 Method of treating cancer using structured lipids
11/11/1992	EP0512042A1 Glp-1 analogs useful for diabetes treatment
11/11/1992	EP0511970A1 Method for preparing an enzymatic hydrolyzate.
11/11/1992	CN1066068A 4-aryl-3-(heteroarylureido) quinoline derivatives
11/11/1992	CA2102808A1 Targeted delivery of bone growth factors
11/11/1992	CA2068261A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/10/1992	US5162359 Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-thion derivatives
11/10/1992	US5162350 Benzothiazolinone compounds
11/10/1992	US5162345 Heterocyclic compounds and their preparation and pharmaceutical formulation

1 ... 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 ... 1298